Tirzepatide follows a weekly dosing schedule, and dose increases typically happen every four weeks during titration
DSIP also should not be viewed as equivalent to approved sleep medicines, behavioral therapy for insomnia, or treatment for a diagnosed condition
This dose has been extensively studied in combination with semaglutide under the investigational name CagriSema, achieving up to 22.7% weight reduction at 68 weeks in phase 3 trials [4]
Every protocol begins with a licensed physician consultation and clinical assessment
The results showed a significant increase in skin density and thickness, with a 67% reduction in wrinkle volume and improved elasticity, as measured by ultrasound and profilometry (Leyden et al., 2002)
Full results may take several months, and the therapy is most effective when combined with a healthy diet and regular exercise